Top compounds associated with response to RPL39


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC 0.25 9e-07
mRNA Docetaxel gCSI pan-cancer AAC 0.24 1e-05
mRNA paclitaxel gCSI pan-cancer AAC 0.23 1e-05
mRNA Gemcitabine gCSI pan-cancer AAC 0.2 0.0005
mRNA etoposide CTRPv2 pan-cancer AAC 0.11 0.0009
mRNA COL-3 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA DBeQ CTRPv2 pan-cancer AAC -0.12 0.002
mRNA YM-155 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA BRD9876:MK-1775 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.33 0.005
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.008
Download CSV